SVB Wealth LLC Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

SVB Wealth LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,347 shares of the healthcare conglomerate’s stock after selling 4,435 shares during the quarter. SVB Wealth LLC’s holdings in UnitedHealth Group were worth $16,503,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Robbins Farley acquired a new stake in UnitedHealth Group in the third quarter valued at $25,000. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $26,000. CGC Financial Services LLC raised its stake in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC raised its stake in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA raised its stake in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Stephens restated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Morgan Stanley lowered their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Oppenheimer restated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Piper Sandler lowered their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $573.80.

UnitedHealth Group Stock Up 5.4 %

UnitedHealth Group stock traded up $23.86 during midday trading on Tuesday, hitting $469.49. 5,987,957 shares of the company were exchanged, compared to its average volume of 4,314,540. The company’s fifty day moving average price is $491.15 and its 200-day moving average price is $515.88. The company has a market cap of $432.84 billion, a PE ratio of 19.62, a price-to-earnings-growth ratio of 1.20 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.54 by $0.37. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the company posted $6.26 EPS. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.7 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 31.54%.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.